Advertisement

Topics

Vermillion Announces Date Change of Second Quarter 2017 Financial Results and Investor Conference Call

08:48 EDT 4 Aug 2017 | PR Newswire

AUSTIN, Texas, Aug. 4, 2017 /PRNewswire/ -- Vermillion, Inc. (Nasdaq: VRML), a bio-analytical solutions company focused on gynecologic disease, announced today that it will now report its second quarter 2017 financial results on Wednesday, August 9, 2017, followed by an investor conference call and webcast at 4:30 p.m. Eastern Time.

Wednesday, August 9th @ 4:30pm Eastern Time

Domestic:

888-437-9274

International:

719-325-2437

Conference ID:

8515049

Webcast:

http://public.viavid.com/index.php?id=125153

Replays, Available through August 23nd

Domestic:

844-512-2921

International:

412-317-6671

Replay PIN:

8515049

About VermillionVermillion, Inc. is dedicated to the discovery, development and commercialization of novel high-value diagnostic and bio-analytical solutions that help physicians diagnose, treat and improve gynecologic health outcomes for women. Vermillion, along with its prestigious scientific collaborators, discovers, develops, and delivers innovative diagnostic and technology tools that help women with serious diseases.

Investor Relations Contact:Michael Wood
LifeSci Advisors LLC
646-597-6983
mwood@lifesciadvisors.com

View original content:http://www.prnewswire.com/news-releases/vermillion-announces-date-change-of-second-quarter-2017-financial-results-and-investor-conference-call-300499863.html

SOURCE Vermillion, Inc.

NEXT ARTICLE

More From BioPortfolio on "Vermillion Announces Date Change of Second Quarter 2017 Financial Results and Investor Conference Call"

Quick Search
Advertisement
 

Relevant Topic

Women's Health
Women's Health - key topics include breast cancer, pregnancy, menopause, stroke Follow and track Women's Health News on BioPortfolio: Women's Health News RSS Women'...